J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM.BO)
INR 1941.8
(4.63%)
INR 1941.8
(4.63%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Revenue | 34.84 Billion | 31.49 Billion | 24.24 Billion | 20.42 Billion | 17.42 Billion | 16.1 Billion |
| Cost of Revenue | 12.14 Billion | 11.68 Billion | 8.42 Billion | 7.17 Billion | 6.54 Billion | 6.21 Billion |
| Gross Profit | 22.69 Billion | 19.81 Billion | 15.81 Billion | 13.25 Billion | 10.88 Billion | 9.88 Billion |
| Operating Expenses | 8.41 Billion | 13.99 Billion | 11.1 Billion | 8.37 Billion | 7.7 Billion | 7.3 Billion |
| Selling, General and Administrative Expenses | 8.11 Billion | 4.92 Billion | 3.16 Billion | 1.98 Billion | 1.74 Billion | 1.74 Billion |
| Research and Development Expenses | 305.63 Million | 355.83 Million | 304.8 Million | 258.95 Million | 251.27 Million | 333.18 Million |
| Other Expenses | - | 99.4 Million | 392.3 Million | 76.17 Million | 67.84 Million | 24.49 Million |
| Cost and Expenses | 20.55 Billion | 25.67 Billion | 19.53 Billion | 15.54 Billion | 14.24 Billion | 13.51 Billion |
| Operating Income | 14.28 Billion | 5.84 Billion | 4.6 Billion | 4.55 Billion | 2.9 Billion | 2.22 Billion |
| Interest Expense | 436.51 Million | 360.5 Million | 51.2 Million | 69.42 Million | 29.17 Million | 43.21 Million |
| Income Tax Expense | 1.98 Billion | 1.45 Billion | 1.18 Billion | 1.48 Billion | 765 Million | 930.22 Million |
| Earnings before Tax | 7.51 Billion | 5.55 Billion | 5.04 Billion | 5.96 Billion | 3.48 Billion | 2.86 Billion |
| Net Income | 5.52 Billion | 4.09 Billion | 3.85 Billion | 4.47 Billion | 2.72 Billion | 1.93 Billion |
| Earnings Per Share Basic | 35.66 | 26.50 | 24.93 | 28.98 | 17.10 | 11.77 |
| Earnings Per Share Diluted | 34.85 | 26.17 | 24.91 | 28.98 | 17.10 | 11.77 |
| Weighted Average Shares Outstanding | 154.95 Million | 154.64 Million | 154.56 Million | 154.56 Million | 159.11 Million | 164.38 Million |
| Weighted Average Shares Outstanding (Diluted) | 158.58 Million | 156.61 Million | 154.71 Million | 154.56 Million | 159.11 Million | 164.38 Million |
| Gross Margin | 0.65 | 0.63 | 0.65 | 0.65 | 0.62 | 0.61 |
| EBIT Margin | 0.27 | 0.22 | 0.24 | 0.28 | 0.22 | 0.19 |
| Profit Margin | 0.16 | 0.13 | 0.16 | 0.22 | 0.16 | 0.12 |
| EBITDA | 9.33 Billion | 7.04 Billion | 5.81 Billion | 6.72 Billion | 4.18 Billion | 3.46 Billion |
| Earnings Before Tax Margin | 0.41 | 0.19 | 0.19 | 0.22 | 0.17 | 0.14 |
| Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
|---|---|---|---|---|---|---|
| Revenue | 10.04 Billion | 8.61 Billion | 34.84 Billion | 8.44 Billion | 8.81 Billion | 8.96 Billion |
| Cost of Revenue | 5.47 Billion | 4.93 Billion | 19.21 Billion | 2.73 Billion | 2.98 Billion | 3.09 Billion |
| Gross Profit | 4.56 Billion | 3.68 Billion | 15.62 Billion | 5.7 Billion | 5.83 Billion | 5.86 Billion |
| Operating Expenses | 2.17 Billion | 2.1 Billion | 8.03 Billion | 3.81 Billion | 3.72 Billion | 3.85 Billion |
| Selling, General and Administrative Expenses | 2.17 Billion | 2.1 Billion | - | 1.96 Billion | 1.91 Billion | 2.05 Billion |
| Research and Development Expenses | - | 305.63 Million | - | - | - | - |
| Other Expenses | 58.9 Million | 166.3 Million | 372.7 Million | 73.5 Million | 76.6 Million | 56.3 Million |
| Cost and Expenses | 7.64 Billion | 7.04 Billion | 27.25 Billion | 6.55 Billion | 6.7 Billion | 6.95 Billion |
| Operating Income | 2.39 Billion | 1.57 Billion | 7.58 Billion | 1.89 Billion | 2.11 Billion | 2 Billion |
| Interest Expense | 56.4 Million | 94.1 Million | 443.3 Million | 124.9 Million | 103.7 Million | 120.6 Million |
| Income Tax Expense | 630.1 Million | 384.4 Million | 1.98 Billion | 503.8 Million | 580.7 Million | 519.8 Million |
| Earnings before Tax | 2.39 Billion | 1.64 Billion | 7.51 Billion | 1.83 Billion | 2.08 Billion | 1.94 Billion |
| Net Income | 1.76 Billion | 1.26 Billion | 5.52 Billion | 1.33 Billion | 1.5 Billion | 1.42 Billion |
| Earnings Per Share Basic | 11.39 | 8.22 | - | 8.62 | 9.72 | 9.20 |
| Earnings Per Share Diluted | 11.39 | 8.06 | - | 8.46 | 9.54 | 9.07 |
| Weighted Average Shares Outstanding | 155.19 Million | 155.04 Million | 155.04 Million | 155.04 Million | 154.92 Million | 154.77 Million |
| Weighted Average Shares Outstanding (Diluted) | 155.19 Million | 157.88 Million | 157.88 Million | 157.88 Million | 157.85 Million | 156.91 Million |
| Gross Margin | 0.45 | 0.43 | 0.45 | 0.68 | 0.66 | 0.65 |
| EBIT Margin | 0.28 | 0.23 | - | 0.27 | 0.28 | 0.27 |
| Profit Margin | 0.18 | 0.15 | 0.16 | 0.16 | 0.17 | 0.16 |
| EBITDA | 2.8 Billion | 1.98 Billion | - | 2.3 Billion | 2.51 Billion | 2.37 Billion |
| Earnings Before Tax Margin | 0.24 | 0.18 | 0.22 | 0.22 | 0.24 | 0.22 |
BASC
SAURASHCEM
301180
ARCHIDPLY
SEB
PPL-PA